334.75 USD
-0.08 (-0.02%)
334.8 USD
+0.05 (+0.01%)
Taking everything into account, SWAV scores 6 out of 10 in our fundamental rating. SWAV was compared to 184 industry peers in the Health Care Equipment & Supplies industry. SWAV has an excellent financial health rating, but there are some minor concerns on its profitability. SWAV is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes SWAV very considerable for growth investing!
1. Profitability
1.1 Basic Checks
- SWAV had positive earnings in the past year.
- SWAV had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: SWAV reported negative net income in multiple years.
- The reported operating cash flow has been mixed in the past 5 years: SWAV reported negative operating cash flow in multiple years.
1.2 Ratios
- SWAV's Return On Assets of 9.95% is amongst the best of the industry. SWAV outperforms 93.23% of its industry peers.
- With an excellent Return On Equity value of 21.76%, SWAV belongs to the best of the industry, outperforming 95.31% of the companies in the same industry.
- SWAV has a Return On Invested Capital of 8.81%. This is amongst the best in the industry. SWAV outperforms 88.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.95% | ||
| ROE | 21.76% | ||
| ROIC | 8.81% |
ROA(3y)13.4%
ROA(5y)-1.2%
ROE(3y)20.17%
ROE(5y)0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- SWAV's Profit Margin of 20.76% is amongst the best of the industry. SWAV outperforms 94.79% of its industry peers.
- With an excellent Operating Margin value of 20.52%, SWAV belongs to the best of the industry, outperforming 94.27% of the companies in the same industry.
- With an excellent Gross Margin value of 86.99%, SWAV belongs to the best of the industry, outperforming 96.35% of the companies in the same industry.
- In the last couple of years the Gross Margin of SWAV has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.52% | ||
| PM (TTM) | 20.76% | ||
| GM | 86.99% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.99%
GM growth 5Y16.42%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SWAV is destroying value.
- Compared to 1 year ago, SWAV has more shares outstanding
- SWAV has a worse debt/assets ratio than last year.
2.2 Solvency
- SWAV has an Altman-Z score of 10.26. This indicates that SWAV is financially healthy and has little risk of bankruptcy at the moment.
- SWAV has a better Altman-Z score (10.26) than 86.98% of its industry peers.
- The Debt to FCF ratio of SWAV is 4.41, which is a neutral value as it means it would take SWAV, 4.41 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 4.41, SWAV belongs to the top of the industry, outperforming 82.81% of the companies in the same industry.
- A Debt/Equity ratio of 0.97 indicates that SWAV is somewhat dependend on debt financing.
- SWAV's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. SWAV is outperformed by 76.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 4.41 | ||
| Altman-Z | 10.26 |
ROIC/WACC0.94
WACC9.36%
2.3 Liquidity
- A Current Ratio of 13.81 indicates that SWAV has no problem at all paying its short term obligations.
- SWAV has a Current ratio of 13.81. This is amongst the best in the industry. SWAV outperforms 97.92% of its industry peers.
- A Quick Ratio of 12.61 indicates that SWAV has no problem at all paying its short term obligations.
- SWAV has a Quick ratio of 12.61. This is amongst the best in the industry. SWAV outperforms 97.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.81 | ||
| Quick Ratio | 12.61 |
3. Growth
3.1 Past
- SWAV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.34%, which is quite good.
- The Revenue has grown by 41.44% in the past year. This is a very strong growth!
- SWAV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 126.31% yearly.
EPS 1Y (TTM)12.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.81%
Revenue 1Y (TTM)41.44%
Revenue growth 3Y120.84%
Revenue growth 5Y126.31%
Sales Q2Q%35.85%
3.2 Future
- Based on estimates for the next years, SWAV will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.56% on average per year.
- Based on estimates for the next years, SWAV will show a very strong growth in Revenue. The Revenue will grow by 20.10% on average per year.
EPS Next Y36.11%
EPS Next 2Y27.65%
EPS Next 3Y24.15%
EPS Next 5Y17.56%
Revenue Next Year27.69%
Revenue Next 2Y24.82%
Revenue Next 3Y23.61%
Revenue Next 5Y20.1%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 78.21, the valuation of SWAV can be described as expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of SWAV indicates a somewhat cheap valuation: SWAV is cheaper than 67.19% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.60. SWAV is valued rather expensively when compared to this.
- With a Price/Forward Earnings ratio of 53.09, SWAV can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of SWAV indicates a somewhat cheap valuation: SWAV is cheaper than 68.75% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 25.83. SWAV is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 78.21 | ||
| Fwd PE | 53.09 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SWAV indicates a somewhat cheap valuation: SWAV is cheaper than 67.19% of the companies listed in the same industry.
- SWAV's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SWAV is cheaper than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 75.65 | ||
| EV/EBITDA | 66.43 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SWAV does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of SWAV may justify a higher PE ratio.
- SWAV's earnings are expected to grow with 24.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.17
PEG (5Y)N/A
EPS Next 2Y27.65%
EPS Next 3Y24.15%
5. Dividend
5.1 Amount
- No dividends for SWAV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SHOCKWAVE MEDICAL INC / SWAV FAQ
What is the fundamental rating for SWAV stock?
ChartMill assigns a fundamental rating of 6 / 10 to SWAV.
What is the valuation status for SWAV stock?
ChartMill assigns a valuation rating of 4 / 10 to SHOCKWAVE MEDICAL INC (SWAV). This can be considered as Fairly Valued.
What is the profitability of SWAV stock?
SHOCKWAVE MEDICAL INC (SWAV) has a profitability rating of 6 / 10.
Can you provide the expected EPS growth for SWAV stock?
The Earnings per Share (EPS) of SHOCKWAVE MEDICAL INC (SWAV) is expected to grow by 36.11% in the next year.